(Q40244998)

18 September 2017

title

New insights on the use of desipramine as an inhibitor for acid ceramidase (English)

1 reference

18 September 2017

Yusuf A Hannun

1 reference

18 September 2017

Saeed Elojeimy

1 reference

18 September 2017

David H Holman

1 reference

18 September 2017

Xiang Liu

1 reference

18 September 2017

Ahmed El-Zawahry

1 reference

18 September 2017

Maristella Villani

1 reference

18 September 2017

Joseph C Cheng

1 reference

18 September 2017

Ayman Mahdy

1 reference

18 September 2017

Youssef Zeidan

1 reference

18 September 2017

Alicja Bielwaska

1 reference

18 September 2017

James S Norris

1 reference

18 September 2017

language of work or name

English

0 references

publication date

4 August 2006

1 reference

18 September 2017

1 reference

18 September 2017

volume

580

1 reference

18 September 2017

1 reference

18 September 2017

page(s)

4751-4756

1 reference

Interactions of acid sphingomyelinase and lipid bilayers in the presence of the tricyclic antidepressant desipramine

18 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Biologically active sphingolipids in cancer pathogenesis and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Cell line dependent involvement of ceramide in ultraviolet light-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Ceramide signaling in fenretinide-induced endothelial cell apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Purification, characterization, and biosynthesis of human acid ceramidase

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Quantitative measurement of different ceramide species from crude cellular extracts by normal-phase high-performance liquid chromatography coupled to atmospheric pressure ionization mass spectrometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Acid ceramidase but not acid sphingomyelinase is required for tumor necrosis factor-{alpha}-induced PGE2 production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Inhibition of lysosomal acid sphingomyelinase by agents which reverse multidrug resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Substrate specificity of bovine cathepsin B and its inhibition by CA074, based on crystal structure refinement of the complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Chloroquine inhibits cell growth and induces cell death in A549 lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Chloroquine-mediated radiosensitization is due to the destabilization of the lysosomal membrane and subsequent induction of cell death by necrosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Human acid ceramidase is overexpressed but not mutated in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

Overexpression of acid ceramidase protects from tumor necrosis factor-induced cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

The ceramide analog, B13, induces apoptosis in prostate cancer cell lines and inhibits tumor growth in prostate cancer xenografts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2006.07.071

10.1016/J.FEBSLET.2006.07.071

21 January 2018

Identifiers

DOI

1 reference

18 September 2017

1 reference